Stock screenerAll disclosures →
EDGAR →
CYRX
Conviction 85HealthcareScan · Mon, Aug 10, 2026CYRX$14.83-1.92%
ResistanceSupportVol 14Insider sellVol MA14 632.37K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price14.83
Change-1.92%
Gap-2.38%
Rel volume1.94×
Avg volume671.43K
Avg $ vol10.49M
SMA 2015.59
SMA 5015.49
SMA 20011.20
Price vs 50-4.25%
Price vs 200+32.45%
MA stackmixed
50/200 cross—
Supertrendup · 14.43
RSI (14)44
MACD hist-0.11
MACD cross—
Stoch %K / %D21 / 20
ADX (14)23
+DI / −DI13 / 24
RSI divergence—
MACD divergence—
ATR %+4.79%
ADR %4.77%
52w high16.57
52w low7.56
From 52w high-10.50%
Above 52w low+96.16%
New 52w highNo
SqueezeOff
Bollinger width15.37%
%B0.18
Donchian pos19.85%
Donchian high16.89
Donchian low14.32
AVWAP (52w high)15.45
vs AVWAP high-4.01%
AVWAP (52w low)11.39
vs AVWAP low+30.20%
OBV trendFlat
Chaikin MF (20)0.05
Today vs 20d1.94×
Avg vol (14d)632.37K
Avg vol (20d)671.43K
Avg $ vol (20d)10.49M
Market cap—
RS 3m (vs SPY)+12.80%
RS 6m (vs SPY)+61.70%
RS line new highNo
Trend template7/8
Technical rank63.1
1 week-4.26%
1 month-8.29%
3 months+9.04%
6 months+70.07%
1 year+80.85%
YTD+55.13%
P/E9.78
P/B1.56
P/S4.35
P/FCF-30.61
EPS1.40
Div yield—
ROE15.96%
ROA10.35%
Debt/Eq0.00
Current2.08
EV/EBITDA-54.74
Gross margin47.14%
Net margin44.44%
Rev growth12.38%
EPS growth168.23%
Price target18.71
Target upside23.74%
Analyst ratingBuy
Institutional103.07%
Ent. value497.84M
Revenue48.97M
Net income-8.26M
Gross profit22.82M
Free cash flow-25.02M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out50.4M
Employees738
ListedFri, Jul 16, 1993
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction85 / 100
Pattern quality—
Tech rank63.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance16.81
Support14.50
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CYRX
No recent disclosed trades by Congress in CYRX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CYRX · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BADDOUR LINDA Director · Common Stock · 2026-06-05 | Grant | 10.35K | $0 | 2026-06-05 | 2026-06-09 |
BADDOUR LINDA Director · Option (Right to Buy Common Stock) · 2026-06-05 | Grant | 16.08K | $0 | 2026-06-05 | 2026-06-09 |
Mandalam Ramkumar Director · Common Stock · 2026-06-08 | Sell | 23.21K | $358K | 2026-06-08 | 2026-06-08 |
Hariri Robert J Director · Common Stock · 2026-06-05 | Grant | 10.35K | $0 | 2026-06-05 | 2026-06-08 |
Mandalam Ramkumar Director · Option (Right to Buy Common Stock) · 2026-06-05 | Grant | 16.08K | $0 | 2026-06-05 | 2026-06-08 |
Hariri Robert J Director · Option (Right to Buy Common Stock) · 2026-06-05 | Grant | 16.08K | $0 | 2026-06-05 | 2026-06-08 |
HANCOCK DANIEL M Director · Option (Right to Buy Common Stock) · 2026-06-05 | Grant | 16.08K | $0 | 2026-06-05 | 2026-06-08 |
HANCOCK DANIEL M Director · Common Stock · 2026-06-05 | Grant | 10.35K | $0 | 2026-06-05 | 2026-06-08 |
Mandalam Ramkumar Director · Common Stock · 2026-06-05 | Grant | 10.35K | $0 | 2026-06-05 | 2026-06-08 |
STEFANOVICH ROBERT Chief Financial Officer · Common Stock · 2026-06-04 | Sell | 169.43K | $2.8M | 2026-06-04 | 2026-06-08 |
SEC filings
EDGAR filings in CYRX · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.